Ulises Alfonso Gómez Pinedo-rekin lankidetzan egindako argitalpenak (31)

2024

  1. Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1G93A mice by reducing inflammatory pathways in the adipose tissue

    Scientific Reports, Vol. 14, Núm. 1

  2. Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities

    Biomolecules, Vol. 14, Núm. 1

  3. Murine experimental models of amyotrophic lateral sclerosis: An update

    Neurologia, Vol. 39, Núm. 3, pp. 282-291

2023

  1. In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies

    Cells, Vol. 12, Núm. 11

  2. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition

    Brain : a journal of neurology, Vol. 146, Núm. 5, pp. 2142-2152

2022

  1. Biomaterial- and stem cell–based treatment strategies for diseases of the central nervous system

    Neurology Perspectives

  2. Cell therapy as a treatment strategy in amyotrophic lateral sclerosis

    Neurology Perspectives, Vol. 2, pp. S69-S73

  3. Chitosan-Hydroxycinnamic Acids Conjugates: Emerging Biomaterials with Rising Applications in Biomedicine

    International journal of molecular sciences, Vol. 23, Núm. 20

  4. Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis

    Life, Vol. 12, Núm. 9

  5. Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders

    Cells, Vol. 11, Núm. 19

  6. The Integration of Cell Therapy and Biomaterials as Treatment Strategies for Remyelination

    Life, Vol. 12, Núm. 4

2021

  1. Intranasal administration of undifferentiated oligodendrocyte lineage cells as a potential approach to deliver oligodendrocyte precursor cells into brain

    International Journal of Molecular Sciences, Vol. 22, Núm. 19

  2. Sera from patients with nmosd reduce the differentiation capacity of precursor cells in the central nervous system

    International Journal of Molecular Sciences, Vol. 22, Núm. 10

2020

  1. Experimental models of demyelination and remyelination

    Neurologia, Vol. 35, Núm. 1, pp. 32-39

  2. NG2 and GFAP co-expression after differentiation in cells transfected with mutant GFAP and in undifferentiated glioma cells

    Neurologia, Vol. 35, Núm. 7, pp. 479-485

  3. Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis

    Frontiers in Neurology, Vol. 11

2019

  1. Biohybrids of scaffolding hyaluronic acid biomaterials plus adipose stem cells home local neural stem and endothelial cells: Implications for reconstruction of brain lesions after stroke

    Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 107, Núm. 5, pp. 1598-1606

  2. Clinical or neuroimaging profiles in the assessment of genetic variants associated with neurodegenerative diseases

    CNS Neuroscience and Therapeutics

  3. Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole-exome next generation sequencing

    Brain and Behavior, Vol. 9, Núm. 4

2018

  1. Evaluation of the Safety and Efficacy of the Therapeutic Potential of Adipose-Derived Stem Cells Injected in the Cerebral Ischemic Penumbra

    Journal of Stroke and Cerebrovascular Diseases, Vol. 27, Núm. 9, pp. 2453-2465